Venky's (India) Limited delivered a strong financial performance for the quarter and year ended 31st March, 2026, with the Board of Directors approving the audited results at their meeting held on 14th May, 2026. The company reported a significant improvement in profitability during the quarter and the full year, driven by improved realizations and operational efficiency across its three business segments. The Board also recommended a dividend of ₹10 per equity share (100%) for the year ended 31st March, 2026, subject to shareholder approval at the ensuing Annual General Meeting. Subsequently, the company conducted an earnings call for its investors on 15th May, 2026, in relation to the financials published for the year ended 31st March, 2026. Following the call, the company filed the transcript of the conference call with the stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Highlights

Revenue from operations for Q4FY26 stood at ₹1,100.47 Cr, compared to ₹843.16 Cr in Q4FY25. Profit After Tax for the quarter surged to ₹101.37 Cr from ₹13.30 Cr in the corresponding period of the previous year. For the full year FY26, the company reported a revenue of ₹3,727.32 Cr and a net profit of ₹139.25 Cr. EBITDA for Q4FY26 stood at ₹1.3B versus ₹254M in Q4FY25, with the EBITDA margin expanding significantly to 11.8% from 3.01% in the same period last year.

The following table summarises the key financial metrics for the quarter and full year:

Segment Performance

All three business segments of the company registered an improvement in performance during the quarter ended 31st March, 2026. The Poultry and Poultry Products segment benefited from improved realizations from the sale of day-old chicks and grow-up birds. The Animal Health Products segment continued to post good results driven by a better product mix and focus on quality. The Oilseed segment saw a significant turnaround owing to higher capacity utilization and its ability to deliver high-quality products in a competitive environment.

The segment-wise revenue and profitability are detailed below:

Balance Sheet & Cash Flow

As at 31st March, 2026, total assets stood at ₹2,30,866 lakhs, up from ₹2,07,033 lakhs as at 31st March, 2025. Total equity increased to ₹1,59,609 lakhs from ₹1,47,558 lakhs. Cash and cash equivalents at the end of the year stood at ₹6,216 lakhs, up from ₹1,488 lakhs at the beginning of the year. Net cash generated by operating activities for the year ended 31st March, 2026 was ₹19,132 lakhs, compared to ₹6,620 lakhs in the previous year.

Key balance sheet items are summarised below:

Dividend Declaration

The Board has recommended a dividend of ₹10 per equity share (100%) for the year ended 31st March, 2026, pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The dividend, if approved by shareholders, will be paid within the statutory time limit following the ensuing Annual General Meeting.

Conference Call Transcript

Venky's (India) Limited conducted an earnings call for its investors on 15th May, 2026, in relation to the financials published for the year ended 31st March, 2026. The company has now filed the transcript of this conference call with the stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was submitted by Rohan Bhagwat, Company Secretary & Compliance Officer.

Venky's (India) Limited delivered robust financial performance in Q3FY26, with net profit surging 138.32% year-on-year to ₹4,858 lakhs. The poultry major's strong operational execution and improved market realisations drove the impressive growth trajectory during the quarter ended December 31, 2025.

Financial Performance Overview

The company's revenue from operations increased 7.76% to ₹95,015 lakhs in Q3FY26 compared to ₹88,161 lakhs in Q3FY25. Total income, including other income, reached ₹96,998 lakhs against ₹81,123 lakhs in the previous quarter and ₹89,340 lakhs in Q3FY25.

Segment-wise Performance

The poultry and poultry products segment emerged as the primary growth driver, benefiting from improved realisations in day-old chicks and grown-up birds sales. The segment reported revenue of ₹49,123 lakhs in Q3FY26. Animal health products contributed ₹8,798 lakhs, while the oilseed segment generated ₹32,577 lakhs in revenue.

Nine-Month Performance

For the nine-month period ended December 31, 2025, Venky's reported revenue from operations of ₹2,62,685 lakhs compared to ₹2,46,383 lakhs in the corresponding period last year. Net profit for the nine-month period stood at ₹10,332 lakhs, reflecting the company's consistent operational performance across segments.

Operational Highlights

Total expenses for Q3FY26 were ₹90,384 lakhs, with cost of materials consumed being the largest component at ₹60,807 lakhs. Employee benefits expense increased to ₹6,424 lakhs, while other expenses totaled ₹11,758 lakhs. The company maintained disciplined cost management while scaling operations.

Corporate Developments and Regulatory Compliance

The Board of Directors approved these audited financial results in their meeting held on February 9, 2026, which commenced at 10:30 AM IST and concluded at 1:30 PM IST. The results were reviewed by the Audit Committee before board approval and subsequently submitted to statutory auditors for their audit report.

The company has submitted its quarterly results to both the National Stock Exchange of India Limited (scrip code: VENKEYS) and Bombay Stock Exchange Limited (scrip code: 523261) under Regulation 33. Company Secretary and Compliance Officer Rohan Bhagwat signed the regulatory filings on February 9, 2026.